|1.||Stepan, N: 1 article (05/2015)|
|2.||Denysenko, O: 1 article (05/2015)|
|3.||Grishina, T I: 1 article (01/2009)|
|4.||Gens, G P: 1 article (01/2009)|
|5.||Vel'sher, L Z: 1 article (01/2009)|
|6.||Platonov, D A: 1 article (01/2009)|
|7.||Korobkova, L I: 1 article (01/2009)|
|8.||Budnenkov, A G: 1 article (01/2009)|
|9.||Gabuniia, Z R: 1 article (01/2009)|
|10.||Germanov, A B: 1 article (01/2009)|
|1.||Duodenal Ulcer (Curling's Ulcer)
05/01/2015 - "Patients with eczema were divided into 3 groups that were prescribed different treatments: the first comparative group (21 patients) - received a standard therapy; the second comparative group (20 patients) - had a standard therapy and additionally an antioxidant preparation "Mexidol", the third (basic group) - 22 patients, who were prescribed a complex therapy with a combination of two drugs with antioxidant effect: "Mexidol" and "Galavit." It was established that multimodality therapy for eczema while using two drugs with antioxidant action ("Mexidol", "Galavit") contributes to the most significant positive dynamics and normalization of the studied parameters of oxidant-antioxidant homeostasis of patients compared to a standard therapy of dermatosis or its combination with antioxidant preparation "Mexidol"."
|4.||Scrub Typhus (Typhus, Scrub)
08/01/2002 - "Comparative study of interleukin-1 and tumor necrosis factor production under conditions of experimental rickettsial infection caused by agents of Astrakhan spotted fever and North Asian scrub typhus showed that therapy with galavit reduced manifestations of the disease, decreased mortality of experimental animals, and decreased the concentrations of interleukin-1 and tumor necrosis factor to normal values."
|1.||Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
|2.||Interleukin-1 (Interleukin 1)